COMMUNIQUÉS West-GlobeNewswire
-
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
08/09/2025 -
CHARM Therapeutics Appoints Dr Erkut Bahceci as Chief Medical Officer
08/09/2025 -
Burning Rock Reports Second Quarter 2025 Financial Results
08/09/2025 -
InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore
08/09/2025 -
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis
08/09/2025
Pages